Clinical characteristics and current management of hepatitis B and C in China

Table 1 Demographic characteristics of the analyzed patient population with hepatitis B virus or hepatitis C virus infections n (%)

Characteristic	HBV (n = 2562)	HCV (n = 1406)	HBV and HCV (n = 42)	All patients (n = 4010)1
Age, yr (mean ± SD)	38.3 (± 12.4)	46.9 (± 13.6)	45.5 (± 11.4)	41.4 (± 13.5)
Gender
Male	1696 (66.2)	652 (46.4)	22 (52.4)	2370 (59.1)
Female	866 (33.8)	754 (53.6)	20 (47.6)	1640 (40.9)
Ethnicity
Han	2431(94.9)	1205 (85.7)	37 (88.1)	3673 (91.6)
Urghur	26 (1.0)	126 (9.0)	2 (4.8)	154 (3.8)
Hui	46 (1.8)	27 (1.9)	2 (4.8)	75 (1.9)
Other	59 (2.3)	48 (3.4)	1 (2.4)	108 (2.7)
Domicility
Urban/suburban	1831 (71.5)	1212 (86.2)	33 (78.6)	3076 (76.7)
Rural	731(28.5)	194 (13.8)	9 (21.4)	934 (23.3)
Alcohol consumption	78 (3.5)	38 (2.7)	0	116 (2.9)
Medical complications	331 (12.9)	394 (28.0)	12 (28.6)	737 (18.4)
Diabetes	40 (1.6)	97 (6.9)	2 (4.8)	139 (3.5)
Liver gallstones	70 (2.7)	50 (3.6)	1 (2.4)	121 (3.0)
Alcoholic liver disease	41 (1.6)	26 (1.8)	1 (2.4)	68 (1.7)
Respiratory disease	24 (0.9)	26 (1.8)	3 (7.1)	53 (1.3)
Coronary artery disease	10 (0.4)	40 (2.8)	1 (2.4)	51 (1.3)
Hepatic complications2
Hepatic cirrhosis	302 (11.8)	180 (12.8)	9 (21.4)	491 (12.2)
Jaundice	178 (7.0)	66 (4.7)	4 (9.5)	248 (6.2)
Ascites	94 (3.7)	46 (3.3)	2 (4.8)	142 (3.5)
Gastrointestinal bleeding	27 (1.1)	15 (1.1)	2 (4.8)	44 (1.1)
Hepatocellular carcinoma	11 (0.4)	13 (0.9)	1 (2.4)	25 (0.6)
Hepatic encephalopathy	4 (0.2)	11 (0.8)	1 (2.4)	16 (0.4)
HBV vaccination status
Never	2009 (78.4)	743 (52.8)	26 (61.9)	2778 (69.3)
Childhood	122 (4.8)	136 (9.7)	3 (7.1)	261 (6.5)
Adult	43 (1.7)	149 (10.6)	0	192 (4.8)
Unknown	388 (15.2)	378 (26.9)	13 (31.0)	779 (19.4)
Pregnant	146 (5.7)3	47 (3.3)	2 (4.8)	195 (4.9)

¹One patient had HDV infection;

²Includes previous complications (3 years prior to at diagnosis) and complications occurring after diagnosis;

³Number includes 1 patient of unknown pregnancy status.